ResMed renews patent battle with F&P
By HME News Staff
Updated Tue September 4, 2018
SAN DIEGO - ResMed has filed a new petition with the U.S. International Trade Commission to stop the alleged infringement of its patented technology by New Zealand-based Fisher & Paykel Healthcare. ResMed seeks an order banning the importation and sale in the U.S. of F&P's Simplus full-face mask, Eson nasal mask and Eson 2 nasal mask for allegedly infringing five ResMed patents related to mask system and cushion design. ResMed has also filed a new lawsuit in the U.S. District Court for the Southern District of California seeking monetary damages, plus an infringement against future sales. F&P, which will contest the allegations, has cut its fiscal year 2019 net profit outlook due to expected legal expenses, according to news reports.
Comments